Debt-to-equity in % of CorMedix Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CorMedix Inc. quarterly Debt-to-equity history and change rate from Q1 2012 to Q3 2025.
  • CorMedix Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 60.1 %, a 168% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CorMedix Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 60.1 +37.7 +168% 30 Sep 2025
Q2 2025 25 +8.81 +54.4% 30 Jun 2025
Q1 2025 32.6 +18 +123% 31 Mar 2025
Q4 2024 30.1 +17.1 +131% 31 Dec 2024
Q3 2024 22.5 +10.7 +90.2% 30 Sep 2024
Q2 2024 16.2 +4.05 +33.4% 30 Jun 2024
Q1 2024 14.7 +4.05 +38.2% 31 Mar 2024
Q4 2023 13 +2.82 +27.6% 31 Dec 2023
Q3 2023 11.8 +2.26 +23.7% 30 Sep 2023
Q2 2023 12.1 +2.98 +32.5% 30 Jun 2023
Q1 2023 10.6 +2.7 +34.2% 31 Mar 2023
Q4 2022 10.2 +3.27 +47% 31 Dec 2022
Q3 2022 9.55 +2.51 +35.7% 30 Sep 2022
Q2 2022 9.17 +1.3 +16.5% 30 Jun 2022
Q1 2022 7.9 -3.53 -30.9% 31 Mar 2022
Q4 2021 6.96 -11.7 -62.7% 31 Dec 2021
Q3 2021 7.04 -16.3 -69.8% 30 Sep 2021
Q2 2021 7.87 -16.3 -67.4% 30 Jun 2021
Q1 2021 11.4 -19.2 -62.7% 31 Mar 2021
Q4 2020 18.7 -19.6 -51.3% 31 Dec 2020
Q3 2020 23.3 -37.8 -61.9% 30 Sep 2020
Q2 2020 24.2 -163 -87.1% 30 Jun 2020
Q1 2020 30.7 -962 -96.9% 31 Mar 2020
Q4 2019 38.3 +554 31 Dec 2019
Q3 2019 61.1 +628 30 Sep 2019
Q2 2019 187 -94.8 -33.6% 30 Jun 2019
Q1 2019 993 +917 +1210% 31 Mar 2019
Q4 2018 -516 -562 -1205% 31 Dec 2018
Q3 2018 -566 -600 -1794% 30 Sep 2018
Q2 2018 282 +254 +919% 30 Jun 2018
Q1 2018 75.8 +55.7 +278% 31 Mar 2018
Q4 2017 46.7 +31.3 +204% 31 Dec 2017
Q3 2017 33.4 +21.1 +171% 30 Sep 2017
Q2 2017 27.7 +18.2 +192% 30 Jun 2017
Q1 2017 20.1 +12 +150% 31 Mar 2017
Q4 2016 15.4 +6.56 +74.6% 31 Dec 2016
Q3 2016 12.4 +2.32 +23.1% 30 Sep 2016
Q2 2016 9.49 -3.24 -25.4% 30 Jun 2016
Q1 2016 8.01 -88.9 -91.7% 31 Mar 2016
Q4 2015 8.8 -663 -98.7% 31 Dec 2015
Q3 2015 10 +847 30 Sep 2015
Q2 2015 12.7 +295 30 Jun 2015
Q1 2015 96.9 +310 31 Mar 2015
Q4 2014 672 +826 31 Dec 2014
Q3 2014 -837 -680 -433% 30 Sep 2014
Q2 2014 -282 -86.3 -44.1% 30 Jun 2014
Q1 2014 -213 +103 +32.5% 31 Mar 2014
Q4 2013 -154 +1.05K +87.2% 31 Dec 2013
Q3 2013 -157 -646 -132% 30 Sep 2013
Q2 2013 -196 -464 -173% 30 Jun 2013
Q1 2013 -316 -435 -364% 31 Mar 2013
Q4 2012 -1.2K 31 Dec 2012
Q3 2012 489 30 Sep 2012
Q2 2012 269 30 Jun 2012
Q1 2012 120 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.